PF-Atlas › Clinical Trials › NCT00775528
Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Pancrelipase Delayed Release · Phase 3
Registry ID
NCT00775528
Phase
Phase 3
Status
Completed
Drug / intervention
Pancrelipase Delayed Release
Sponsor
Solvay Pharmaceuticals
Start
2009-04
About this trial
Pancrelipase Delayed Release is evaluated in NCT00775528, a Phase 3 idiopathic pulmonary fibrosis study sponsored by Solvay Pharmaceuticals. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT00775528 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.